Photodynamic therapy using talaporfin sodium for non-totally resectable malignant glioma

Background: For malignant glioma, intraoperative photodynamic therapy (PDT) using talaporfin sodium is a powerful tool for local tumor control, when gross total removal is performed. However, the efficacy of PDT for non-totally resectable malignant glioma has not been clearly confirmed. Therefore, t...

Full description

Saved in:
Bibliographic Details
Main Authors: Shinjiro Fukami, Jiro Akimoto, Kenta Nagai, Yuki Saito, Michihiro Kohno
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:Photodiagnosis and Photodynamic Therapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1572100023005963
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850263860192215040
author Shinjiro Fukami
Jiro Akimoto
Kenta Nagai
Yuki Saito
Michihiro Kohno
author_facet Shinjiro Fukami
Jiro Akimoto
Kenta Nagai
Yuki Saito
Michihiro Kohno
author_sort Shinjiro Fukami
collection DOAJ
description Background: For malignant glioma, intraoperative photodynamic therapy (PDT) using talaporfin sodium is a powerful tool for local tumor control, when gross total removal is performed. However, the efficacy of PDT for non-totally resectable malignant glioma has not been clearly confirmed. Therefore, the purpose of this study was to clarify the usefulness of PDT using talaporfin sodium for non-totally resectable malignant glioma. Methods: Eighteen patients with malignant glioma (16 new onset, 2 recurrent) in whom gross total removal was judged to be difficult from the images obtained before surgery were evaluated. Fifteen patients had glioblastoma (14 newly diagnosed, 1 recurrent), and 3 patients had anaplastic oligodendroglioma (2 newly diagnosed, 1 recurrent). The whole resection cavity was subjected to PDT during the surgery. For newly diagnosed glioblastoma, postoperative therapy involved the combined use of radiation and temozolomide. Bevacizumab treatment was also started at an early stage after surgery. Results: In some patients, reduction of the residual tumor was observed at an early stage of chemoradiotherapy after the surgery, suggesting the positive effect of PDT. Recurrence occurred in 15 of the 18 patients during the course of treatment. Distant recurrence occurred in 8 of these 15 patients, despite good local tumor control. In the 14 patients with newly diagnosed glioblastoma, the median progression-free survival was almost 10.5 months, and the median overall survival was almost 16.9 months. Conclusions: PDT for malignant glioma is expected to slightly improve local tumor control for non-totally resectable lesions.
format Article
id doaj-art-30c1188f38d24539b352c8f4529d194f
institution OA Journals
issn 1572-1000
language English
publishDate 2024-02-01
publisher Elsevier
record_format Article
series Photodiagnosis and Photodynamic Therapy
spelling doaj-art-30c1188f38d24539b352c8f4529d194f2025-08-20T01:54:51ZengElsevierPhotodiagnosis and Photodynamic Therapy1572-10002024-02-014510386910.1016/j.pdpdt.2023.103869Photodynamic therapy using talaporfin sodium for non-totally resectable malignant gliomaShinjiro Fukami0Jiro Akimoto1Kenta Nagai2Yuki Saito3Michihiro Kohno4Department of Neurosurgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-023, Japan; Corresponding author.Department of Neurosurgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-023, Japan; Department of Neurosurgery, Kohsei Chuo General Hospital, Tokyo, JapanDepartment of Neurosurgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-023, JapanDepartment of Neurosurgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-023, JapanDepartment of Neurosurgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-023, JapanBackground: For malignant glioma, intraoperative photodynamic therapy (PDT) using talaporfin sodium is a powerful tool for local tumor control, when gross total removal is performed. However, the efficacy of PDT for non-totally resectable malignant glioma has not been clearly confirmed. Therefore, the purpose of this study was to clarify the usefulness of PDT using talaporfin sodium for non-totally resectable malignant glioma. Methods: Eighteen patients with malignant glioma (16 new onset, 2 recurrent) in whom gross total removal was judged to be difficult from the images obtained before surgery were evaluated. Fifteen patients had glioblastoma (14 newly diagnosed, 1 recurrent), and 3 patients had anaplastic oligodendroglioma (2 newly diagnosed, 1 recurrent). The whole resection cavity was subjected to PDT during the surgery. For newly diagnosed glioblastoma, postoperative therapy involved the combined use of radiation and temozolomide. Bevacizumab treatment was also started at an early stage after surgery. Results: In some patients, reduction of the residual tumor was observed at an early stage of chemoradiotherapy after the surgery, suggesting the positive effect of PDT. Recurrence occurred in 15 of the 18 patients during the course of treatment. Distant recurrence occurred in 8 of these 15 patients, despite good local tumor control. In the 14 patients with newly diagnosed glioblastoma, the median progression-free survival was almost 10.5 months, and the median overall survival was almost 16.9 months. Conclusions: PDT for malignant glioma is expected to slightly improve local tumor control for non-totally resectable lesions.http://www.sciencedirect.com/science/article/pii/S1572100023005963Malignant gliomaPhotodynamic therapyNon-totally resectable lesionTalaporfin sodiumSub-total resection
spellingShingle Shinjiro Fukami
Jiro Akimoto
Kenta Nagai
Yuki Saito
Michihiro Kohno
Photodynamic therapy using talaporfin sodium for non-totally resectable malignant glioma
Photodiagnosis and Photodynamic Therapy
Malignant glioma
Photodynamic therapy
Non-totally resectable lesion
Talaporfin sodium
Sub-total resection
title Photodynamic therapy using talaporfin sodium for non-totally resectable malignant glioma
title_full Photodynamic therapy using talaporfin sodium for non-totally resectable malignant glioma
title_fullStr Photodynamic therapy using talaporfin sodium for non-totally resectable malignant glioma
title_full_unstemmed Photodynamic therapy using talaporfin sodium for non-totally resectable malignant glioma
title_short Photodynamic therapy using talaporfin sodium for non-totally resectable malignant glioma
title_sort photodynamic therapy using talaporfin sodium for non totally resectable malignant glioma
topic Malignant glioma
Photodynamic therapy
Non-totally resectable lesion
Talaporfin sodium
Sub-total resection
url http://www.sciencedirect.com/science/article/pii/S1572100023005963
work_keys_str_mv AT shinjirofukami photodynamictherapyusingtalaporfinsodiumfornontotallyresectablemalignantglioma
AT jiroakimoto photodynamictherapyusingtalaporfinsodiumfornontotallyresectablemalignantglioma
AT kentanagai photodynamictherapyusingtalaporfinsodiumfornontotallyresectablemalignantglioma
AT yukisaito photodynamictherapyusingtalaporfinsodiumfornontotallyresectablemalignantglioma
AT michihirokohno photodynamictherapyusingtalaporfinsodiumfornontotallyresectablemalignantglioma